Sun Pharma bags rights to $3.7 billion cholesterol drug market globally
Sun Pharma will commercialise and manufacture LIB Therapeutics' once-monthly cholesterol drug outside the US and China after its EU approval
We haven't written up this one. Business Standard IN has the full story — the link below goes straight to it.